Literature DB >> 30080825

Gene therapy rescues newborns with spinal muscular atrophy.

Cormac Sheridan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30080825     DOI: 10.1038/nbt0818-669

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Big win possible for Ionis/Biogen antisense drug in muscular atrophy.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2016-10-11       Impact factor: 54.908

2.  Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy.

Authors:  Jerry R Mendell; Samiah Al-Zaidy; Richard Shell; W Dave Arnold; Louise R Rodino-Klapac; Thomas W Prior; Linda Lowes; Lindsay Alfano; Katherine Berry; Kathleen Church; John T Kissel; Sukumar Nagendran; James L'Italien; Douglas M Sproule; Courtney Wells; Jessica A Cardenas; Marjet D Heitzer; Allan Kaspar; Sarah Corcoran; Lyndsey Braun; Shibi Likhite; Carlos Miranda; Kathrin Meyer; K D Foust; Arthur H M Burghes; Brian K Kaspar
Journal:  N Engl J Med       Date:  2017-11-02       Impact factor: 91.245

3.  Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN.

Authors:  Christian Hinderer; Nathan Katz; Elizabeth L Buza; Cecilia Dyer; Tamara Goode; Peter Bell; Laura K Richman; James M Wilson
Journal:  Hum Gene Ther       Date:  2018-02-12       Impact factor: 5.695

  3 in total
  1 in total

Review 1.  Emerging technologies for cystic fibrosis transmembrane conductance regulator restoration in all people with CF.

Authors:  Marie E Egan
Journal:  Pediatr Pulmonol       Date:  2021-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.